263 related articles for article (PubMed ID: 21326208)
1. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.
Bennetzen MF; Wellner N; Ahmed SS; Ahmed SM; Diep TA; Hansen HS; Richelsen B; Pedersen SB
Int J Obes (Lond); 2011 Nov; 35(11):1377-84. PubMed ID: 21326208
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise.
You T; Disanzo BL; Wang X; Yang R; Gong D
Lipids Health Dis; 2011 Oct; 10():194. PubMed ID: 22035053
[TBL] [Abstract][Full Text] [Related]
3. Investigations of the endocannabinoid system in adipose tissue: effects of obesity/ weight loss and treatment options.
Bennetzen MF
Dan Med Bull; 2011 Apr; 58(4):B4269. PubMed ID: 21466769
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
[TBL] [Abstract][Full Text] [Related]
5. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese.
Bennetzen MF; Nielsen TS; Paulsen SK; Bendix J; Fisker S; Jessen N; Lund S; Richelsen B; Pedersen SB
Eur J Clin Invest; 2010 Feb; 40(2):121-6. PubMed ID: 20039929
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.
Blüher M; Engeli S; Klöting N; Berndt J; Fasshauer M; Bátkai S; Pacher P; Schön MR; Jordan J; Stumvoll M
Diabetes; 2006 Nov; 55(11):3053-60. PubMed ID: 17065342
[TBL] [Abstract][Full Text] [Related]
7. Activation of the peripheral endocannabinoid system in human obesity.
Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Janke J; Bátkai S; Pacher P; Harvey-White J; Luft FC; Sharma AM; Jordan J
Diabetes; 2005 Oct; 54(10):2838-43. PubMed ID: 16186383
[TBL] [Abstract][Full Text] [Related]
8. Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.
Stolic M; Russell A; Hutley L; Fielding G; Hay J; MacDonald G; Whitehead J; Prins J
Int J Obes Relat Metab Disord; 2002 Jan; 26(1):17-23. PubMed ID: 11791142
[TBL] [Abstract][Full Text] [Related]
9. Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects.
Engeli S; Lehmann AC; Kaminski J; Haas V; Janke J; Zoerner AA; Luft FC; Tsikas D; Jordan J
Obesity (Silver Spring); 2014 May; 22(5):E70-6. PubMed ID: 24616451
[TBL] [Abstract][Full Text] [Related]
10. Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss.
Wamberg L; Christiansen T; Paulsen SK; Fisker S; Rask P; Rejnmark L; Richelsen B; Pedersen SB
Int J Obes (Lond); 2013 May; 37(5):651-7. PubMed ID: 22828938
[TBL] [Abstract][Full Text] [Related]
11. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity.
Kempf K; Hector J; Strate T; Schwarzloh B; Rose B; Herder C; Martin S; Algenstaedt P
Horm Metab Res; 2007 Aug; 39(8):596-600. PubMed ID: 17712725
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans.
Bordicchia M; Battistoni I; Mancinelli L; Giannini E; Refi G; Minardi D; Muzzonigro G; Mazzucchelli R; Montironi R; Piscitelli F; Petrosino S; Dessì-Fulgheri P; Rappelli A; Di Marzo V; Sarzani R
Metabolism; 2010 May; 59(5):734-41. PubMed ID: 19919870
[TBL] [Abstract][Full Text] [Related]
14. Peripheral endocannabinoid system activity in patients treated with sibutramine.
Engeli S; Heusser K; Janke J; Gorzelniak K; Bátkai S; Pacher P; Harvey-White J; Luft FC; Jordan J
Obesity (Silver Spring); 2008 May; 16(5):1135-7. PubMed ID: 18356837
[TBL] [Abstract][Full Text] [Related]
15. Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
Di Marzo V; Verrijken A; Hakkarainen A; Petrosino S; Mertens I; Lundbom N; Piscitelli F; Westerbacka J; Soro-Paavonen A; Matias I; Van Gaal L; Taskinen MR
Eur J Endocrinol; 2009 Nov; 161(5):715-22. PubMed ID: 19745037
[TBL] [Abstract][Full Text] [Related]
16. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.
Kolehmainen M; Vidal H; Alhava E; Uusitupa MI
Obes Res; 2001 Nov; 9(11):706-12. PubMed ID: 11707537
[TBL] [Abstract][Full Text] [Related]
17. The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans.
Cable JC; Tan GD; Alexander SP; O'Sullivan SE
Lipids Health Dis; 2011 Aug; 10():129. PubMed ID: 21813022
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
[TBL] [Abstract][Full Text] [Related]
19. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.
Matias I; Gonthier MP; Orlando P; Martiadis V; De Petrocellis L; Cervino C; Petrosino S; Hoareau L; Festy F; Pasquali R; Roche R; Maj M; Pagotto U; Monteleone P; Di Marzo V
J Clin Endocrinol Metab; 2006 Aug; 91(8):3171-80. PubMed ID: 16684820
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human.
Buch C; Muller T; Leemput J; Passilly-Degrace P; Ortega-Deballon P; Pais de Barros JP; Vergès B; Jourdan T; Demizieux L; Degrace P
Front Endocrinol (Lausanne); 2021; 12():716431. PubMed ID: 34434170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
